Genetic complexity of Alzheimer's disease;Complexité génétique de la maladie d'Alzheimer

Revue Neurologique

Volumn 160, Issue 2, 2004, Pages 251-255

  Chartier Harlin, M C ^a   Araria Goumidi, L ^a   Lambert, J C ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; PRESENILIN 1; PRESENILIN 2;

ALLELE; ALZHEIMER DISEASE; CHROMOSOME 12; CONFERENCE PAPER; DISEASE PREDISPOSITION; FAMILIAL DISEASE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; LINKAGE ANALYSIS; NONHUMAN; ONSET AGE; PATHOPHYSIOLOGY; RISK FACTOR; TECHNIQUE;

EID: 1542314381     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0035-3787(04)70899-1     Document Type: Conference Paper

References (29)

1. ARTIGA MJ, BULLIDO MJ, SASTRE I, et al. (1998). Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene. FEBS Lett, 421: 105-8.
2. ABRAHAM R, MYERS A, WAVRANT-DEVRIEZE F, et al. (2001). Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease. Hum Genet, 109:646-52.
3. BERR C, LAMBERT JC, SAZDOVITCH V, et al. (2001). Neuropathological epidemiology of cerebral aging: a study of two genetic polymorphisms. Neurobiol Aging, 22: 227-35.
4. BLACKER D, WILCOX MA, LAIRD NM, et al. (1998). Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat Genet, 19: 357-60.
5. BULLIDO MJ, ARTIGA MJ, RECUERO M, et al. (1998). A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nat Genet, 18: 69-71.
6. CAMPION D, DUMANCHIN C, HANNEQUIN D, et al. (1999). Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet, 65: 664-70.
7. DEMENAIS F, MARTINEZ M, LATHROP M. (1996). Méthodes staititiques pour identifier les gènes dans les maladies multifactorielles. Annales de l'Institut Pasteur, 7: 3-12.
8. EDITORS. (1999). Freely associating. Nat Genet, 22: 1-2.
9. FARRER LA, CUPPLES LA, HAINES JL, et al. (1997). Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA, 278: 1349-56.
10. HARDY J. (1997). Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci, 20:154-159.
11. HOLTZMAN DM, BALES KR, TENKOVA T, et al. (2000). Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A, 97: 2892-7.
12. KOSTER MN, DERMAUT B, CRUTS M, et al. (2000) The alpha2-macroglobulin gene in AD: a population-based study and meta-analysis. Neurology, 55: 678-84.
13. LAMBERT JC, ARARIA-GOUMIDI L, MYLLYKANGAS L, et al. (2002) Contribution of APOE promoter polymorphisms to Alzheimer's disease risk. Neurology, 59: 59-66.
14. LAMBERT JC, BERR C, PASQUIER F, et al. (1998) Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease. Hum Mol Genet, 7: 1511-16.
15. LAMBERT JC, GOUMIDI L, VRIEZE FW, et al. (2000). The transcriptional factor LBP-1c/CP2/LSF gene on chromosome 12 is a genetic determinant of Alzheimer's disease. Hum Mol Genet, 9: 2275-80.
16. LAMBERT JC, MANN D, GOUMIDI L, et al. (2001). Effect of the APOE promoter polymorphisms on cerebral amyloid peptide deposition in Alzheimer's disease. Lancet, 357: 608-09.
17. LENDON CL, TALBOT CJ, CRADDOCK NJ, HAN SW, WRAGG M, MORRIS JC, GOATE AM. (1997). Genetic association studies between dementia of the Alzheimer's type and three receptors for apolipoprotein E in a Caucasian population. Neurosci Lett, 222: 187-90.
18. LENDON C, CRADDOCK N. (2001). Susceptibility gene(s) for Alzheimer's disease on chromosome 10. Trends Neurosci, 24: 557-559.
19. LUEDECKING-ZIMMER E, DEKOSKY ST, CHEN Q, BARMADA MM, KAMBOH MI. (2002). Investigation of oxidized LDL-receptor 1 (OLR1) as the candidate gene for Alzheimer's disease on chromosome 12. Hum Genet, 111: 443-51.
20. MYERS AJ, GOATE AM. (2001). The genetics of late-onset Alzheimer's disease. Curr Opin Neurol, 14: 433-440.
21. PERICAK-VANCE MA, GRUBBER J, BAILEY LR, et al. (2000). Identification of novel genes in late-onset Alzheimer's disease. Exp Gerontol, 35: 1343-1352.
22. REBECK GW, PERLS TT, WEST HL, SODHI P, LIPSITZ LA, HYMAN BT. (1994). Reduced apolipoprotein epsilon 4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals. Neurology, 44: 1513-16.
23. SCOTT HD, LAAKE K. (2001). Statins for prevention of Alzheimer's disease. Cochrane Database Syst Rev. 2001, 4: CD003160.
24. SCOTT WK, GRUBBER JM, CONNEALLY PM, et al. (2000). Fine mapping of the chromosome 12 late-onset Alzheimer disease locus: potential genetic and phenotypic heterogeneity. Am J Hum Genet, 66: 922-32.
25. TODD JA. (1999). Interpretation of results from genetic studies of multifactorial diseases. Lancet 354, Suppl 1: SI15-6.
26. TUCKER H.M., KIHIKO-EHMANN M, ESTUS S. (2002). Urokinase-type plasminogen activator inhibits amyloid-beta neurotoxicity and fibrillogenesis via plasminogen. J Neurosci Res, 70: 249-55.
27. WARWlCK DAW E, PAYAMI H, NEMENS EJ, NOCHLIN D, BIRD TD, SCHELLENBERG GD, WIJSMAN EM. (2000). The number of trait loci in late-onset Alzheimer disease. Am J Hum Genet, 66: 196-204.
28. WOLOZIN B. (2001). A fluid connection: cholesterol and Abeta. Proc Natl Acad Sci U S A, 98: 5371-73.
29. ZURUTUZA L, VERPILLAT P, RAUX G, et al. (2000). APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population. Eur J Hum Genet, 8: 713-6